Financials

News Ideas Discussions Technicals Seasonals

CMOTEC_B fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Scandinavian ChemoTech AB is a medical technology company, which engages in the development of patented technology platform. It also offers cancer patients access to a new treatment alternative, tumour specific electroporation, available for treatment of both humans and animals. The company was founded by Stefan Mohan Frick, Bertil Persson, and Klaus Gustav Göran Hellers on February 25, 2015 and is headquartered in Lund, Sweden.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

CMOTEC_B has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company